1. Home
  2. PXED vs NNNN Comparison

PXED vs NNNN Comparison

Compare PXED & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$33.11

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$14.53

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
NNNN
Founded
1976
2021
Country
United States
Germany
Employees
3400
27
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PXED
NNNN
Price
$33.11
$14.53
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$44.29
N/A
AVG Volume (30 Days)
82.1K
36.2K
Earning Date
04-07-2026
04-07-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.49
N/A
P/E Ratio
$11.20
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$23.52
$10.50
52 Week High
$38.19
$55.65

Technical Indicators

Market Signals
Indicator
PXED
NNNN
Relative Strength Index (RSI) 59.69 31.90
Support Level $28.40 $14.66
Resistance Level $33.05 $30.21
Average True Range (ATR) 1.34 2.37
MACD 0.07 -0.19
Stochastic Oscillator 91.44 8.90

Price Performance

Historical Comparison
PXED
NNNN

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: